Post-Pandemic Readiness: Preparing for the Aftermath of COVID-19 on the Medical Device Industry

Global Medical Device Podcast · 23 Dec 2020 · 42m · Episode 173

What this episode covers

Steven Niedelman and Eric Henry from King & Spalding discuss post-pandemic readiness for the medical device industry, focusing on the transition from Emergency Use Authorizations (EUAs) to full regulatory compliance. They explain the current state of FDA inspections, the role of the Medical Device Single Audit Program (MDSAP), and the critical need for companies to build or remediate Quality Management Systems (QMS) before EUAs are revoked. The guests advise on preparing for pre-submission meetings with the FDA and managing the logistical challenges of a massive influx of regulatory submissions.

Most relevant to

companies scaling up

Topics

Mentioned

Companies
King & Spalding, FDA, Green Light Guru
Also
MDSAP, 21 CFR Part 820, ISO 13485, EU MDR, 510(k), PMA

Other shows on the same ground, closest first.

  • Let's Combinate · 9m

    256 - The New FDA Inspection Playbook: Where to Start with QMSR

    Subhi Saadeh, founder of Let’s Combinate, introduces a four-part series on FDA inspection readiness under the new Quality Management System Regulation (QMSR), explaining how the retired QSIT framework has been replaced by Compliance Program 7382.850. He highlights advice from former FDA investigator Eric Pittman, who advises industry to focus exclusively on Section III of compliance programs as the primary roadmap for inspections. The episode details the shift from QSIT’s four major subsystems to six QMS areas, emphasizing a risk-based approach where investigators evaluate product risks and control effectiveness.

  • Being an Engineer · 51m

    S5E29 Steve Gompertz | Medical Device Quality Control & Regulatory Requirements

    Steve Gompertz, a partner at QRx Partners with prior leadership roles at Medtronic, Boston Scientific, St. Jude Medical, and Pelican Biothermal, explains how to build scalable quality management systems for medical device companies. He details the evolution of regulatory frameworks, noting the shift toward stricter EU standards and the integration of AI and cybersecurity into device compliance. Gompertz emphasizes tailoring quality systems to company size, using a case study of a client who reduced FDA findings from dozens to zero by implementing a holistic, process-connected system rather than a checklist approach. He also advocates for concurrent engineering and cross-functional teams to accelerate development while maintaining rigorous safety standards.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Let's Combinate · 52m

    128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture

    Vin Cafiso, former FDA Consumer Safety Officer and Managing Consultant at Practical Compliance Results, discusses the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and its impact on small medical device companies. He explains how FDA inspection methodologies are shifting from issue-focused 483s to process-based QSET audits, emphasizing the importance of understanding quality culture through simple engagement rather than rigid metrics. Cafiso shares insights from his career at companies like BD and Smith & Nephew, highlighting how starting as an investigator builds a strong foundation for industry roles by providing a broad view of quality systems across diverse products and company sizes.

  • Let's Combinate · 10m

    198 - QMSR Explained, ISO 13485 Compared, and 5 Key Things You Might’ve Missed

    Subhi Saadeh, host of Let's Combinate and Quality Professional, breaks down five critical aspects of the FDA's new Quality Management System Regulation (QMSR). He explains that while QMSR harmonizes with ISO 13485, it retains 21 CFR 820 with FDA-specific overlays like UDI and complaint handling, and removes previous exemptions for certain manufacturers. Saadeh emphasizes that risk management remains mandatory despite not being explicitly named in the text, and warns that companies must complete gap assessments and training before the February 2, 2026 compliance deadline.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.